Instantaneous mutation rate in cancer initiation and progression

Abstract

BackgroundCancer is one of the leading causes for the morbidity and mortality worldwide. Although substantial studies have been conducted theoretically and experimentally in recent years, it is still a challenge to explore the mechanisms of cancer initiation and progression. The investigation for these problems is very important for the diagnosis of cancer diseases and development of treatment schemes.ResultsTo accurately describe the process of cancer initiation, we propose a new concept of gene initial mutation rate based on our recently designed mathematical model using the non-constant mutation rate. Unlike the widely-used average gene mutation rate that depends on the number of mutations, the gene initial mutation rate can be used to describe the initiation process of a single patient. In addition, we propose the instantaneous tumour doubling time that is a continuous function of time based on the non-constant mutation rate. Our proposed concepts are supported by the clinic data of seven patients with advanced pancreatic cancer. The regression results suggest that, compared with the average mutation rate, the estimated initial mutation rate has a larger value of correlation coefficient with the patient survival time. We also provide the estimated tumour size of these seven patients over time.ConclusionsThe proposed concepts can be used to describe the cancer initiation and progression for different patients more accurately. Since a quantitative understanding of cancer progression is important for clinical treatment, our proposed model and calculated results may provide insights into the development of treatment schemes and also have other clinic implications.

Single-cell phylogenies reveal changes in the evolutionary rate within cancer and healthy tissues

“…However, the mutation rate in cancer cells can increase during tumor progression, for example, due to genetic alterations in DNA repair pathways. 37 , 38 , 39 , 40 , 41 , 42 A change in the somatic mutation rate of particular cell lineages will lead to varying evolutionary rates in the cell population, even under neutral evolution, possibly leading to false rejections of neutrality by the VAF-based tests. 22 , 26 Still, the interplay between somatic mutation rates and selection is complex, and changes in the mutation rate might, in some cases, result from selection favoring higher mutability in some genes.…”

A Strategic Review on Carbon Quantum Dots for Cancer-Diagnostics and Treatment

“…Cancer is caused by the uncontrolled growth of cells, ultimately these extra abnormal cells produce an unusual mass of tissues i.e., tumors. Despite the advances in medical science, cancer is still a major challenge to early diagnosis and treatment due to the high mutation rate and metastasis of cancer cells ( Sun et al, 2018 ). Radiotherapy and chemotherapy are the typical ways to fight cancer.…”